血清胱蛋白酶抑制剂C诊断老年高血压早期肾损害

Evaluation of Serum Cystatin C (Cyst-c) Levels in Detecting Early Renal Damage in elderly Hypertensive Patients 1

  • 摘要: 目的 观察老年高血压患者血清胱蛋白酶抑制剂C(Cyst-c)浓度对检出早期肾损害的价值。方法 对412例老年高血压患者同时测血Cyst-c和血肌酐(Cr)浓度,并与正常对照组对照。结果412例老年高血压患者中早期肾损害197例(占47.82%),肾功能不全24例(5.82%),肾功能正常191例(46.36%)。在早期肾损害组:血Cyst-c浓度明显高于对照组(2.3±0.8 vs 0.9±0.2)mg/L,P<0.01),而血Cr浓度两组无显著性差异(86.6±12.7 vs 81.0±10.5)μmol/L,P>0.05。结论 老年高血压患者中,早期肾损害占47.82%,很常见。血Cyst-c能检出血Cr不能检出的早期肾损害。

     

    Abstract: Objective To study the value of serum Cystatin C (Cyst-c) levels in detecting early renal damage in old hypertension patients. Methods Serum Cyst-c and creatinine (Cr) levels were determined in 412 old hypertension patients and compare with a control group(n=30). Results Among 412 patients, there was early renal damage in 197 cases(47.82%), renal failure in 24 cases(5.82%), normal renal function in 191 cases(46.36%). Serum Cyst-c levels in the early renal damage group was higher than the controlled group (2.34±0.8 and 0.9±0.2)mg/L, P<0.01. There was no difference in serum Cr levels between the early renal damage group and the control group (86.6±12.7 and 81.0±10.5)μmol/L, P>0.05. Conclusion Serum Cyst-c levels is a sensitive indicator for detecting early renal damage which was not found by serum Cr.

     

/

返回文章
返回